Drug Stocks To Watch: Hospira (NYSE:HSP), Valeant Pharmaceuticals (NYSE:VRX), Alkermes Plc (NASDAQ:ALKS), pSivida Corp. (NASDAQ:PSDV)

Posted by on Feb 18, 2014

Hospira, Inc.’s (NYSE:HSP) fourth quarter 2013 adjusted earnings of 51 cents per share surpassed the Zacks Consensus Estimate by a penny. Fourth quarter 2013 earnings were however below the year-ago figure by 7.3%. Hospira, Inc. (NYSE:HSP) stock opened at $44.09 in last session, and closed at $43.55, while the day range of HSP stock is $43.38 – $44.29. The stock showed a positive weekly performance of 1.54%.

Aegis Capital maintains Valeant Pharmaceuticals Intl Inc (NYSE:VRX) at Buy with a 12-month price target of $160 following the announcement Monday that it will acquire PreCision Dermatology. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock opened at $141.62, in last session and closed at $139.57, by losing -1.57%. The 52 week range of VRX is $64.05 – $142.82. Company’s market capitalization is $46.50billion.

Shares of Alkermes PLC (NASDAQ:ALKS) have earned a consensus rating of “Hold” from the thirteen analysts that are covering the stock. Alkermes Plc (NASDAQ:ALKS) stock decreased -1.55% and finished the last session at $51.32. The EPS of the stock remained 0.13. Company’s market capitalization is $6.96billion.

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release, drug delivery products for treating eye diseases, announced that the Scottish Medicines Consortium (SMC) has accepted ILUVIEN(R) for use within the National Health Service (NHS) Scotland under a simple patient access scheme. pSivida Corp. (NASDAQ:PSDV) stock opened the session at $4.52, and closed the session at $4.36. The 52 week range of the PSDV stock remained $1.60 – $5.60 and the day range was $4.35 – $4.54.

Leave a Reply

Your email address will not be published. Required fields are marked *